PACAP and type I PACAP receptors in human prostate cancer tissue

Costanzo Moretti, Caterina Mammi, Giovanni Vanni Frajese, Stefania Mariani, Lucio Gnessi, Mario Arizzi, Francesca Wannenes, Gaetano Frajese

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We characterized the expression and localization of pituitary adenylate cyclase-activating polypeptide (PACAP) and its specific type I receptor variants in prostatic, hyperplastic, and carcinomatous tissue collected from patients undergoing prostate biopsy and surgery for benign prostatic hyperplasia (BPH) and prostate cancer (PCa). The immunohistochemical studies using an indirect immunoperoxidase technique evidenced positive immunostaining for PACAP in the cytoplasm of epithelial cells of hyperplastic and carcinomatous prostate specimens and in some scattered cells of the stroma. Type I PACAP receptors (PAC1 R) in healthy and BPH tissues were localized in all epithelial cells lining the lumen of the acini and in some stromal cells, while in specimens from PCa the anti-PAC1 R antibody stained the apical portion of a large percentage of cells. Furthermore, our molecular studies provide evidence that several PAC1 R isoforms (null, SV1/SV2) are present in normal, hyperplastic, and neoplastic tissue, the null variant being the most intensely expressed in PCa. These observations provide additional evidence for a role of PACAP and PAC1 R in the events determining the outcome of PCa.

Original languageEnglish
Pages (from-to)440-449
Number of pages10
JournalAnnals of the New York Academy of Sciences
Volume1070
DOIs
Publication statusPublished - Jul 2006

Fingerprint

Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
Pituitary Adenylate Cyclase-Activating Polypeptide
Prostatic Neoplasms
Tissue
Biopsy
Linings
Prostatic Hyperplasia
Surgery
Protein Isoforms
Epithelial Cells
Antibodies
Stromal Cells
Prostate Cancer
Cells
Immunoenzyme Techniques
Prostate
Cytoplasm

Keywords

  • BPH
  • PAC1 R
  • PACAP
  • PACAP receptor variants
  • Prostate
  • Prostate cancer
  • SV1
  • SV2
  • SV3

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Moretti, C., Mammi, C., Frajese, G. V., Mariani, S., Gnessi, L., Arizzi, M., ... Frajese, G. (2006). PACAP and type I PACAP receptors in human prostate cancer tissue. Annals of the New York Academy of Sciences, 1070, 440-449. https://doi.org/10.1196/annals.1317.059

PACAP and type I PACAP receptors in human prostate cancer tissue. / Moretti, Costanzo; Mammi, Caterina; Frajese, Giovanni Vanni; Mariani, Stefania; Gnessi, Lucio; Arizzi, Mario; Wannenes, Francesca; Frajese, Gaetano.

In: Annals of the New York Academy of Sciences, Vol. 1070, 07.2006, p. 440-449.

Research output: Contribution to journalArticle

Moretti, C, Mammi, C, Frajese, GV, Mariani, S, Gnessi, L, Arizzi, M, Wannenes, F & Frajese, G 2006, 'PACAP and type I PACAP receptors in human prostate cancer tissue', Annals of the New York Academy of Sciences, vol. 1070, pp. 440-449. https://doi.org/10.1196/annals.1317.059
Moretti, Costanzo ; Mammi, Caterina ; Frajese, Giovanni Vanni ; Mariani, Stefania ; Gnessi, Lucio ; Arizzi, Mario ; Wannenes, Francesca ; Frajese, Gaetano. / PACAP and type I PACAP receptors in human prostate cancer tissue. In: Annals of the New York Academy of Sciences. 2006 ; Vol. 1070. pp. 440-449.
@article{574f39523f1d4e76b0b8ed494b38a514,
title = "PACAP and type I PACAP receptors in human prostate cancer tissue",
abstract = "We characterized the expression and localization of pituitary adenylate cyclase-activating polypeptide (PACAP) and its specific type I receptor variants in prostatic, hyperplastic, and carcinomatous tissue collected from patients undergoing prostate biopsy and surgery for benign prostatic hyperplasia (BPH) and prostate cancer (PCa). The immunohistochemical studies using an indirect immunoperoxidase technique evidenced positive immunostaining for PACAP in the cytoplasm of epithelial cells of hyperplastic and carcinomatous prostate specimens and in some scattered cells of the stroma. Type I PACAP receptors (PAC1 R) in healthy and BPH tissues were localized in all epithelial cells lining the lumen of the acini and in some stromal cells, while in specimens from PCa the anti-PAC1 R antibody stained the apical portion of a large percentage of cells. Furthermore, our molecular studies provide evidence that several PAC1 R isoforms (null, SV1/SV2) are present in normal, hyperplastic, and neoplastic tissue, the null variant being the most intensely expressed in PCa. These observations provide additional evidence for a role of PACAP and PAC1 R in the events determining the outcome of PCa.",
keywords = "BPH, PAC1 R, PACAP, PACAP receptor variants, Prostate, Prostate cancer, SV1, SV2, SV3",
author = "Costanzo Moretti and Caterina Mammi and Frajese, {Giovanni Vanni} and Stefania Mariani and Lucio Gnessi and Mario Arizzi and Francesca Wannenes and Gaetano Frajese",
year = "2006",
month = "7",
doi = "10.1196/annals.1317.059",
language = "English",
volume = "1070",
pages = "440--449",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - PACAP and type I PACAP receptors in human prostate cancer tissue

AU - Moretti, Costanzo

AU - Mammi, Caterina

AU - Frajese, Giovanni Vanni

AU - Mariani, Stefania

AU - Gnessi, Lucio

AU - Arizzi, Mario

AU - Wannenes, Francesca

AU - Frajese, Gaetano

PY - 2006/7

Y1 - 2006/7

N2 - We characterized the expression and localization of pituitary adenylate cyclase-activating polypeptide (PACAP) and its specific type I receptor variants in prostatic, hyperplastic, and carcinomatous tissue collected from patients undergoing prostate biopsy and surgery for benign prostatic hyperplasia (BPH) and prostate cancer (PCa). The immunohistochemical studies using an indirect immunoperoxidase technique evidenced positive immunostaining for PACAP in the cytoplasm of epithelial cells of hyperplastic and carcinomatous prostate specimens and in some scattered cells of the stroma. Type I PACAP receptors (PAC1 R) in healthy and BPH tissues were localized in all epithelial cells lining the lumen of the acini and in some stromal cells, while in specimens from PCa the anti-PAC1 R antibody stained the apical portion of a large percentage of cells. Furthermore, our molecular studies provide evidence that several PAC1 R isoforms (null, SV1/SV2) are present in normal, hyperplastic, and neoplastic tissue, the null variant being the most intensely expressed in PCa. These observations provide additional evidence for a role of PACAP and PAC1 R in the events determining the outcome of PCa.

AB - We characterized the expression and localization of pituitary adenylate cyclase-activating polypeptide (PACAP) and its specific type I receptor variants in prostatic, hyperplastic, and carcinomatous tissue collected from patients undergoing prostate biopsy and surgery for benign prostatic hyperplasia (BPH) and prostate cancer (PCa). The immunohistochemical studies using an indirect immunoperoxidase technique evidenced positive immunostaining for PACAP in the cytoplasm of epithelial cells of hyperplastic and carcinomatous prostate specimens and in some scattered cells of the stroma. Type I PACAP receptors (PAC1 R) in healthy and BPH tissues were localized in all epithelial cells lining the lumen of the acini and in some stromal cells, while in specimens from PCa the anti-PAC1 R antibody stained the apical portion of a large percentage of cells. Furthermore, our molecular studies provide evidence that several PAC1 R isoforms (null, SV1/SV2) are present in normal, hyperplastic, and neoplastic tissue, the null variant being the most intensely expressed in PCa. These observations provide additional evidence for a role of PACAP and PAC1 R in the events determining the outcome of PCa.

KW - BPH

KW - PAC1 R

KW - PACAP

KW - PACAP receptor variants

KW - Prostate

KW - Prostate cancer

KW - SV1

KW - SV2

KW - SV3

UR - http://www.scopus.com/inward/record.url?scp=33746422499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746422499&partnerID=8YFLogxK

U2 - 10.1196/annals.1317.059

DO - 10.1196/annals.1317.059

M3 - Article

C2 - 16888207

AN - SCOPUS:33746422499

VL - 1070

SP - 440

EP - 449

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -